Hasan Onal

Hasan Onal

Auto-generated profile, based on publicly available information

Hasan Onal

Department of Pediatrics, Başakşehir Çam and Sakura City Hospital, University of Health Sciences, İstanbul, Türkiye

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2021 in TURKISH JOURNAL OF BIOLOGY
Verified
Journal Article
Open access
HÖHasan Önal
Hasan Önal
BABengü Arslan
Bengü Arslan
NENurcan Üçüncü Ergun
Nurcan Üçüncü Ergun
ŞTŞeyma Topuz
Şeyma Topuz
SSSeda Yilmaz Semerci
Seda Yilmaz Semerci
AKAli Kocataş
Ali Kocataş
Scientific research continues on new preventive and therapeutic strategies against severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). So far, there is no proven curative treatment, and a valid alternative therapeutic approach needs to be developed. This study is designed to evaluate the effect of quercetin in COVID-19 treatment. This was a single-centre, prospective randomized controlled cohort study. Routine care versus QCB (quercetin, vitamin C, bromelain) supplementation was compared between 429 patients with at least one chronic disease and moderate-to-severe respiratory symptoms. Demographic features, signs, laboratory results and drug administration data of patients were recorded. The endpoint was that QCB supplementation was continued throughout the follow-up period from study baseline to discharge, intubation, or death. The most common complaints at the time of hospital admission were fatigue (62.4%), cough (61.1%), anorexia (57%), thirst (53.7%), respiratory distress (51%) and chills (48.3%). The decrease in CRP and ferritin levels was higher in the QCB group (all Ps were < 0.05). In the QCB group, the increase in platelet and lymphocyte counts was higher (all Ps were < 0.05). QCB did not reduce the risk of events during follow-up. Adjustments for statistically significant parameters, including the lung stage, use of favipiravir and presence of comorbidity did not change the results. While there was no difference between the groups in terms of event frequency, the QCB group had more advanced pulmonary findings. QCB supplement is shown to have a positive effect on laboratory recovery. While there was no difference between the groups in terms of event frequency, QCB supplement group had more advanced pulmonar findings, and QCB supplement is shown to have a positive effect on laboratory recovery/results. Therefore, we conclude that further studies involving different doses and plasma level measurements are required to reveal the dose/response relationship and bioavailability of QCB for a better understanding of the role of QCB in the treatment of SARS CoV-2.

3 April 2021 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
ÖBÖmer Faruk Beşer
Ömer Faruk Beşer
FCFugen Cullu Cokugras
Fugen Cullu Cokugras
GDGuzide Dogan
Guzide Dogan
ÖAÖzlem Akgün
Özlem Akgün
MEMurat Elevli
Murat Elevli
Yvan VandenplasYvan Vandenplas
Yvan Vandenplas

19 February 2010 in European Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
HOHasan Onal
Hasan Onal
EAErdal Adal
Erdal Adal
SASeçil Alpaslan
Seçil Alpaslan
AEAtilla Ersen
Atilla Ersen
AAAhmet Aydin
Ahmet Aydin

7 February 2012 in Acta Paediatrica
Verified
Journal Article
Closed access
PDF file
HOHasan Onal
Hasan Onal
OEOya Ercan
Oya Ercan
EAErdal Adal
Erdal Adal
AEAtilla Ersen
Atilla Ersen
ZOZerrin Onal
Zerrin Onal

1 January 2012 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
AEAtilla Ersen
Atilla Ersen
HOHasan Onal
Hasan Onal
DYDüzgün Yıldırım
Düzgün Yıldırım
EAErdal Adal
Erdal Adal
To investigate uterine and ovarian ultrasonography in healthy girls and establish reliable cut-off limits in the Turkish population. The study was performed on 90 girls between 6 and 16 years of age with bone age, hormonal evaluation and pelvic ultrasounds. Total uterine length (TUL), anteroposterior diameters of corpus (COAP), anteroposterior diameters of cervix (CEAP), fundus/cervix ratio (F/C), uterine volume (UV), ovarian volume (OV) and morphology were obtained. The data were stratified according to various pubertal stages and ages. Age-related increases of pelvic organs were noted after 10-10.9 years. Significant correlation was detectable between age and OV, TUL and UV in pubertal girls, but age only correlated with OV in prepubertal girls. A cut-off value of 4 cm for TUL, 2.57 cm(3) for UV and 1.58 cm(3) for OV were the best discrimination values for entering puberty. The data herein may be useful in screening cases around puberty when continuous changes take place.

1 June 2019 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
IEİhsan Esen
İhsan Esen
EBElvan Bayramoğlu
Elvan Bayramoğlu
MYMelek Yıldız
Melek Yıldız
MAMurat Aydın
Murat Aydın
EKEsin Karakilic‐Ozturan
Esin Karakilic‐Ozturan
ESElif Sağsak
Elif Sağsak
Objective: To determine the demographic and biochemical features of childhood and juvenile thyrotoxicosis and treatment outcome. Methods: We reviewed the records of children from 22 centers in Turkey who were diagnosed with thyrotoxicosis between 2007 to 2017. Results: A total of 503 children had been diagnosed with thyrotoxicosis at the centers during the study period. Of these, 375 (74.6%) had been diagnosed with Graves' disease (GD), 75 (14.9%) with hashitoxicosis and 53 (10.5%) with other less common causes of thyrotoxicosis. The most common presenting features in children with GD or hashitoxicosis were tachycardia and/or palpitations, weight loss and excessive sweating. The cumulative remission rate was 17.6% in 370 patients with GD who had received anti-thyroid drugs (ATDs) for initial treatment. The median (range) treatment period was 22.8 (0.3-127) months. No variables predictive of achieving remission were identified. Twenty-seven received second-line treatment because of poor disease control and/or adverse events associated with ATDs. Total thyroidectomy was performed in 17 patients with no recurrence of thyrotoxicosis and all became hypothyroid. Ten patients received radioiodine and six became hypothyroid, one remained hyperthyroid and restarted ATDs and one patient achieved remission. TWo patients were lost to follow up. Conclusion: This study has demonstrated that using ATDs is the generally accepted first-line approach and there seems to be low remission rate with ATDs in pediatric GD patients in Turkey.